CompletedNot Applicable

Effect of Intravenous 5% Dextrose Infusion During Recovery from Anesthesia on the Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy

China102 participantsStarted 2024-03-15

Plain-language summary

The aim of this study was to determine the effect of intravenous infusion of 5% dextrose injection during the recovery period of anesthesia for painless gastroenteroscopy on the patient's blood glucose level, incidence of hypoglycemia and time of awakening from anesthesia, postoperative vertigo, postoperative nausea and vomiting, and quality of recovery in the early postoperative period.

Who can participate

Age range18 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients who meet the indications for painless gastrointestinal endoscopy and are aged 18 to 79 years.
✓. The patient or his/her guardian or immediate family members gave informed consent;
✓. American Society of Anesthesiology (ASA) anesthesia risk classification ≤ grade III.

Exclusion criteria

✕. Patients with contraindications to sedation/anesthesia for gastrointestinal endoscopy: e.g., severe hepatic and renal dysfunction, cardiac insufficiency;
✕. Patients receiving chemotherapy and opioid treatment; patients with a history of sleep apnea hypoventilation syndrome;
✕. Intravenous nutritional support within 8 hours prior to the examination;
✕. Patients diagnosed with type I or type II diabetes.

What they're measuring

Preoperative blood glucose 30min

Timeframe: Measurements taken 0.5 hours Preoperative.

Postoperative blood glucose 2h

Timeframe: Measured at 2 hours postoperatively.

Dizziness level

Timeframe: Approximately 15min after surgery

Dizziness level

Timeframe: Measured at 0.5 hours postoperatively.

Postoperative nausea and vomiting

Timeframe: Measured at 0.5 hours postoperatively.

Postoperative nausea and vomiting

Timeframe: Measured at 2 hours postoperatively.

Trial details

NCT IDNCT06319144

SponsorWeifang Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-20

View on ClinicalTrials.gov More Insulin Resistance trials

Plain-language summary

Who can participate

Age range18 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients who meet the indications for painless gastrointestinal endoscopy and are aged 18 to 79 years.
✓. The patient or his/her guardian or immediate family members gave informed consent;
✓. American Society of Anesthesiology (ASA) anesthesia risk classification ≤ grade III.

Exclusion criteria

✕. Patients with contraindications to sedation/anesthesia for gastrointestinal endoscopy: e.g., severe hepatic and renal dysfunction, cardiac insufficiency;
✕. Patients receiving chemotherapy and opioid treatment; patients with a history of sleep apnea hypoventilation syndrome;
✕. Intravenous nutritional support within 8 hours prior to the examination;
✕. Patients diagnosed with type I or type II diabetes.

What they're measuring

Preoperative blood glucose 30min

Timeframe: Measurements taken 0.5 hours Preoperative.

Postoperative blood glucose 2h

Timeframe: Measured at 2 hours postoperatively.

Dizziness level

Timeframe: Approximately 15min after surgery

Dizziness level

Timeframe: Measured at 0.5 hours postoperatively.

Postoperative nausea and vomiting

Timeframe: Measured at 0.5 hours postoperatively.

Postoperative nausea and vomiting

Timeframe: Measured at 2 hours postoperatively.